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1. Introduction
Articular cartilage is a hyaline cartilage that consists primarily of extracellular matrix with a
sparse population of cells, lacking blood vessels, lymphatic vessels and nerves. The only cell
type within cartilage is the chondrocyte and has a low level of metabolic activity with little or
no cell division and is the responsible for maintaining in a low-turnover state the unique
composition and organization of the matrix that was determined during embryonic and
postnatal development. The biological and mechanical properties of articular cartilage depend
on the interactions between the chondrocytes and the matrix that maintain the tissue. Chon‐
drocytes form the macromolecular framework of the tissue matrix from three classes of
molecules: collagens, proteoglycans, and non-collagenous proteins and maintain the extrac‐
ellular matrix (ECM) by low-turnover replacement of certain matrix proteins [1, 2].
Aggrecan and type II collagen are the most abundant proteins found within the ECM in the
articular cartilage and they are linked together by a number of collagen-binding proteins
including cartilage oligomeric matrix protein (COMP), chondroadherin and other minor
collagens on their surface. Aggrecan is a large aggregating proteoglycan which is in association
with hyaluronan (HA) and link protein (LP). These aggregates are responsible for the turgid
and they provide the osmotic properties to resist compressive loads and retain water. Also
contain a variety of small leucine-rich repeat proteoglycans (SLRPs) as decorin, biglycan,
fibromodulin and lumican where they help maintain the integrity of the tissue and modulate
its metabolism [3, 4].
© 2013 García-Carvajal et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Alteration in cartilage composition in Osteoarthritis (OA)
The chondrocyte is responsible for both the synthesis and the breakdown of the cartilaginous
matrix but the mechanisms that control this balance are poorly understood [4]. The distribution
of load across the joint is an important function of the articular cartilage for avoid excessive
load affecting both cartilage and bone. It has been demonstrated that articular chondrocytes
are able to respond to mechanical injury where biological stimuli such as cytokines and growth
and differentiation factors contribute to structural changes in the surrounding cartilage matrix.
It has been demonstrated that many non-mechanical and mechanical factors such as load
clearly have a role in the initiation and propagation the processes of OA. The OA is the most
common joint disease allowing dysfunction and pain. The OA is characterized by changes in
chondrocyte metabolism that leads to elevated production of proteolytic enzymes, cartilage
damage and loss of joint function. It have been described several mechanisms that can lead to
OA, among of these mechanisms are mechanicals, bone changes and changes in the cartilage
extracellular matrix [5, 6]
Aging, cartilage senescence and reactive oxygen species (ROS) are normal changes in the
musculoskeletal system that contribute to the development of OA, but the mechanisms are
poorly understood [5]. Inflammation is considered as a very early event in OA perhaps induced
by joint trauma affecting chondrocytes in the cartilage and synovial cells (fibroblasts and
macrophages) to produce cytokines as interleukin-1-beta (IL-1β) and tumoral necrosis factor-
alpha (TNF-α), and other signaling molecules as proteoglycans to switch to or increase
catabolic processes [6]. Obesity has been described as a risk factor for OA by increased
mechanical load factors and degenerative knee pain. The mechanisms between obesity and
OA are not completly understood but, it has been found the release of fat molecules that can
affect the processes in the joint, including adipokines as visfatin and leptin, perhaps affecting
the inflammatory response [7, 9]. Malalignment of the knee joint plays an important role in the
development of early osteoarthritis changing the center of pressure of articular cartilage and
subchondral bone. Varus or valgus malalignment of the lower extremity results in an abnormal
load distribution across the medial and lateral tibiofemoral compartment and being increased
in patients with knee osteoarthritis and is increased in patients with overweight. However,
studies examining the relationship between malalignment and early knee osteoarthritis have
produced conflicting results. The association between malalignment and OA changes is based
on radiographic changes mainly and different multicenter OA studies [10-12]. Meniscus is an
important tissue in the system of the knee. It is function is the load transmission and absortion
shock. Complete or partial loss of meniscal tissue alters the biomechanical and biological of
the knee joint modifying the pattern of load distribution and the instability of the knee.
Meniscal narrowing, cartilage loss and chondral lesions increase the risk of secondary OA with
cartilage degeneration. This secondary OA is associated to chondral damage, ligamentous
instability, and malalignment with reduction in the shock absorption capacity of the knee
[13-15]. Extrussion has been associated with articular changes according to their depth into
partial-thickness and full-thickens defects. Partial-thickness lesions are considered less
symptomatic with little evidence of progression on osteoarthritis. Full-thickness chondral and
osteochondral lesions frequently cause symptoms, and they are considered to predispose to
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premature osteoarthritis [16]. Osteochondritis dissecans studies have demonstrated knee joint
dysfunction and high prevalence of osteoarthritic change after fragment removal and all the
studies take in account the limitation of a small defect size from 1.5 to 4.0 cm2 as well the zone
and the location of the defect in the cartilage [17, 18]. The anterior cruciate ligament (ACL) is
the knee ligament most common disrupted. ACL lesion frequently is associated to other
ligamentous structures like, menisci, the articular cartilage or subchondral plate [19, 20].
3. Articular cartilage homeostasis
Articular cartilage is composed of four distinct regions and they differ in their collagen fibril
orientation: (a) the superficial or tangential zone (200 μm), (b) the middle or transitional zone,
(c) the deep or radial zone and (d) the calcified cartilage zone. The superficial zone is composed
of thin collagen fibrils in tangential array parallel to surface with a high concentration of
decorin and lubricin and a low concentration of aggrecan. The middle zone is composed thicker
collagen fibrils more random organized. The deep zone is composed the collagen bundles
thickest and arranged in a radial fashion, orthogonal to the surface, and the calcified cartilage
zone, located above subchondral bone and the tidemark that persists after growth plate closure
and is composed of matrix vesicles, vascularization and innervation from the subchondral
bone. The collagen type in the calcified zone surrounding the cells is type X as in the hypertrofic
zone of the growth plate [21, 22], [23]. From the superficial to the deep zone, cell density
progressively decreases. The chondrocytes in the superficial zone are small and flattened. The
chondrocytes in the middle zone are rounded, and the deep zone chondrocytes are grouped
in columns or clusters and they are larger and express markers of the hypertrophy as well.
Differences in expression of zonal subpopulations may determine the zonal differences in
matrix composition and in the mechanical environment [24, 25].
Chondrocytes live at low oxygen tension within the cartilage matrix, ranging from 10% at the
surface to less than 1% in the deep zones. In vitro, chondrocytes adapt to low oxygen tensions
by up-regulating hypoxia-inducible factor-1-alpha (HIF-1α), which stimulate expression of
glucose transport via constitutive glucose transporter proteins (GLUTs) and angiogenic factors
such as vascular endothelial growth factor (VEGF) as well as a number of genes associated
with cartilage anabolism and chondrocyte differentiation [26, 27].
It is no clear how chondrocytes maintain their ECM under normal conditions since they lack
access to the vascular system but gene expression and protein synthesis may be activated by
injury. The aging may affect the properties of normal cartilage by altering the content,
composition and structural organization of collagen and proteoglycans. The normal function
of the articular cartilage within the joint is to be elastic and have high tensile strength and these
properties depend on the extracellular matrix [28]. The chondrocytes produce, in appropriate
amounts, this ECM that consist of structural macromolecules of type II collagen fibers,
proteoglycans, non-collagenous proteins and glycoproteins, organized into a highly ordered
molecular framework. The collagen matrix gives cartilage its form and tensile strength.
Proteoglycans and non-collagenous proteins bind to the collagenous network and help to
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stabilize the matrix framework and bind the chondrocytes to the macromolecules of the
network. The matrix protects the cells from injury due to normal use of the joint, determines
the types and concentrations of molecules that reach the cells and helps to maintain the
chondrocyte phenotype [29, 30].
The ECM surrounding the chondrocytes has been divided into zones depending on their
distance from the cell. The pericellular matrix is localized immediately around the cell, the
territorial matrix is next to pericellular matrix and the most distance is the interterritorial
matrix. Each matrix zone is characterized by different types of collagens as shown in figure 1.
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Figure 1. The organization of normal articular cartilage. The organization of chondrocytes is divided in superficial,
middle or transitional, deep or radial and calcified cartilage zones with a boundary or tidemark between the first three
zones and the calcified zone. The extracellular matrix is divided depending the distance from the chondrocytes. The
pericellular zone is the matrix surrounding immediately the chondrocytes. The territorial zone is the next to pericellu‐
lar zone and the interterritorial zone is the most distant. Every zone has specific characteristics related with the shape
of the chondrocyte as well the activity and the expression of different molecules by the cell.
The pericellular matrix is a region surrounding chondrocytes in the articular cartilage where
diverse molecules as growth factors have interaction with the receptors expressed on the
membrane cell of chondrocyte. This region is rich in proteoglycans as aggrecan, hyaluronan
and decorin. Type II, VI and IX are collagen most concentrated in the pericellular network of
thin fibrils as fibronectin. Type VI collagen forms part of the matrix immediately surrounding
Regenerative Medicine and Tissue Engineering368
the chondrocytes and may help them to attach to the macromolecular framework of the matrix.
This pericellular matrix enclosed cells has been termed chondron. The territorial zone contains
type VI collagen microfibrils but little or no fibrillar collagen. The interterritorial cartilage
matrix is composed of a collagen type II, type XI collagen and type IX collagen integrated in
the fibril surface with the non-collagen domain, permitting association with other matrix
components and retention of proteoglycans. These collagens give to the cartilage form, tensile
stiffness and strength [31-33].
Cartilage contains a variety of proteoglycans that are essential for its normal function. These
include aggrecan, decorin, biglycan, fibromodulin and lumican each proteoglycan has several
functions determined. The proteoglycans are very important for protecting the collagen
network. Other non-collagen molecules as the matrilins and cartilage oligomeric protein
(COMP) are also present in the matrix. COMP acts as a catalyst in collagen fibrillogenesis, and
interactions between type IX collagen and COMP or matrilin-3 are essential for proper
formation and maintenance of the articular cartilage matrix. Perlecan enhances fibril forma‐
tion, and collagen VI microfibrils connect to collagen II and aggrecan via complexes of
matrilin-1 and biglycan or decorin [34].
Throughout life, the cartilage undergoes continual internal remodeling and the chondrocytes
replace matrix macromolecules lost through degradation. Therefore normal matrix turnover
depends on the ability of chondrocytes to detect alterations in the macromolecular composition
and organization of the matrix, including the presence of degraded molecules, and to respond
by synthesizing appropriate types and amounts of new molecules. In addition, the matrix acts
as a signal transducer for the cells. Loading of the tissue due to use of the joint creates me‐
chanical, electrical, and physicochemical signals that help to direct the synthetic and degra‐
dative activity of chondrocytes [22, 35].
4. Extracellular matrix and cell signaling
Chondrocytes respond to the mechanical and biochemical changes in ECM through signaling
events by various cell surface growth factor receptors and adhesion molecules. ECM proteins
can determine the cell behavior, polarity, migration, differentiation, proliferation and survival
by communicating with the intracellular cytoskeleton and transmission of growth factor
signals. Integrins and proteoglycans are the major ECM adhesion receptors, which cooperate
in signaling events, determining the signaling events, and thus the cell function [36].
Integrins are heterodimeric transmembrane receptors formed of eighteen α subunits and
eight β subunits and they are non-covalently assembled into 24 combinations. The integrin
dimers bind to different ECM molecules with overlapping binding affinities determining
expression  patterns  and the  downstream signaling  events  in  the  cell.  Integrins  respond
specifically  to  the  molecular  composition and physical  properties  of  the  ECM and inte‐
grate both mechanical and chemical signals through direct association with the cytoskele‐
ton. Integrins recognize and bind to the Arg-Gly-Asp (RGD) motif that they are attachment
sites  for  integrin mediated cell  adhesion.  It  has been demonstrated that  high density of
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RGD motifs  allows a precise spatial  distribution pattern of  integrins for specific  cellular
response among ligand molecules [36, 37].
Integrins can activate several signaling pathways independently and frequently they act
synergistically with other growth factor receptors as insulin receptor, type 1 insulin-like
growth factor receptor, VEGF receptor, TGF-b receptor, platelet-derived growth factor-b
(PDGF-b) receptor and epidermal growth factor (EGF) receptor [37,38].
4.1. Role of proteoglycans in signal regulation
The heparan sulfate proteoglycans (HSPGs) contribute to the organization of the matrix by
binding to the many core matrix molecules via HS chains as laminin, fibronectin and collagen.
The chondroitin sulphate proteoglycans (CSPGs) as aggrecan, versican, brevican and the small,
leucine-rich proteoglycans such as decorin and biglycan also bind to and regulate a number
of growth factors, such as members of the TGF family. The hyaluronic acid is a glycosamino‐
glycan synthesized on the cell surface and is responsible for the gel-like consistency of cartilage
by its hydroscopic properties [36, 39].
4.2. Remodelation and degradation of ECM
During normal or pathologic physiology of the cartilage, the ECM must be remodeling and
degraded to allow the chondrocytes for processing and deposition of new matrix by specific
proteases. There are two well-known families of proteases that are involved in the biology of
the ECM, the matrix metalloproteinase (MMP) and the desintegrins and metalloproteinases
with thrombospondin motif (ADAMTS) families. The MMP-13 is involved in the cleavage of
fibromodulin and type IX collagen and is present and active in the pathological process of
cartilage as OA and rheumatoid arthritis. The aggrecanases family’s ADAMTS-4 and
ADAMTS-5 play an important role in cartilage damage during early OA which cleavage the
glycosaminoglycans chains that are the key contributors to the maintenance of the charge
density, the osmotic environment and water retain important characteristics of the mechanical
properties of the cartilage [40, 41].
5. Alterations of the ECM in the skeletal tissue: Injuries and pathologies
The extracellular matrix has structural and functional relevance, it’s a highly organized and
assembled macromolecular structure, also provide cellular adhesion environments, activation
and inactivation of growth factors and regulatory cytokines. The proteolytic processing of
ECM components, results in the production of fragments with biological effects on migration,
proliferation and cellular organization.
When any component of the ECM has a disorder, could generate chondrodysplasia, it means
alterations in the development and growth of cartilage. Chondrodysplasias are caused by
various mutations in genes involved in cartilage development and finally in the formation and
growth of the long bones. These mutations also often alter the formation of other tissues.
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Achondrogenesis type II, is a chondrodysplasia classified as collagenopathy type II. In this
family are located several chondrodysplasia caused by mutations in the gene for collagen II,
which is the most abundant protein in cartilage [42]. These dysplasias are, achondrogenesis
type II, hypochondrogenesis, congenital espondiloepiphysial dysplasia and Kniest dysplasia,
among others. Collagen II is a homotrimer (three identical chains encoded by the COL2A1
gene located on chromosome 12. This collagen is mainly found in the hyaline cartilage and
vitreous humor, so its deficiency is associated with abnormalities of the spine, of the epiphysis
and eye problems. Despite their differences these dysplasias share clinical and radiological
manifestations, so the axial skeleton is affected more than the limbs, cleft palate, myopia and
retinal degeneration [43].
Furthermore, other disorders of matrix components such as collagen IX and XI, which interact
with the collagen II to form supramolecular structures, are closely related phenomena.
It is found that the Osteogenesis Imperfecta (OI) is caused by molecular defects of collagen
type I[44] and metaphyseal chondrodysplasia Schmid type is caused by errors in collagen type
X biosynthesis [45], the latter is characterized by alterations in vertebrae and in the metaphysis
of long bones, also show reduction of the area of reserve cartilage in growth plate and in the
articular cartilage, alters the contents of bone and there is an atypical distribution of the matrix
components of the growth plate.
The cartilage oligomeric matrix protein (COMP) is a member trombospondins family, and its
alteration causes pseudoachondroplasia, this disorder shows short limbs and lax ligaments
[46], the growth plate is shorter and the area of hypertrophic cartilage is reduced.
Cartilage needs molecular signals for development and maintenance, such as growth factors,
which in many cases are regulating the synthesis of the ECM, and may be found active or latent
in the extracellular matrix. Bone morphogenetic proteins (BMPs), transforming growth factor
beta (TGF-β), growth and differentiation factor 5 (GDF-5), are signals related to the develop‐
ment and growth of cartilage, alterations in these molecules cause some malformations, such
as the brachypodism (short limbs) [47].
Cartilage matrix is rich in sulfated proteoglycans and the gene encoding for sulfate transporter
called DTDST (Dystrophic Dysplasia Sulfate Transporter) in patients with dystrophic dyspla‐
sia was found mutations in this gene, and shown to be deficient cartilage sulfating [48].
Campomelic dysplasia is a rare disease associated with XY individuals who possess varying
degrees of sex reversal. SOX-9 is a transcription factor structurally related to the gene SRY (sex-
determining region Y) required for testicular development. However, SOX-9 also directly
regulates the gene for type II collagen, the main molecule of the cartilage matrix and therefore
of chondrocyte differentiation [49, 50, 51].
The inactivation of the gene coding for the mouse gelatinase B, defined the mechanism that
controls the final step of the chondrocyte maturation [52]. Gelatinase B is an enzyme present
in the extracellular matrix of cartilage and its activity is related to the control of apoptosis of
hypertrophic chondrocytes and the vascular tissue. This study hypothesized the existence of
chondroclast, these cells of myeloid origin express gelatinase-B and are located in the cartilage/
bone region and resorb cartilage matrix.
Cartilage Tissue Engineering: The Role of Extracellular Matrix (ECM) and Novel Strategies
http://dx.doi.org/10.5772/55917
371
Based on the above is to emphasize the importance of the extracellular matrix as a modulator
of cellular differentiation of chondrocytes, the extracellular components correlate with the
differentiation state. That is, collagen I is present at early stages of differentiation and matu‐
ration, in mesenchyme and perichondrium; collagen II is on mature cartilage and collagen X
is exclusive of hypertrophic cartilage also collagen type I are expressed in terminal stages of
chondrocytes [53].
The ECM not only serves as a binder that gives form to tissues in addition to their structural
role has physiological functions. The chondrocytes are in the array a series of signals that allows
them to gain some cell shape and organization of the cytoskeletal network. Cell morphology
that can modulate many physiological functions such as proliferation, differentiation, cell
death and gene expression. This transmembrane receptor-mediated would be able to receive
the extracellular signal from the ECM and transduce the signal into the cell, triggering a
response by the chondrocyte differentiation [54].
Integrins are transmembrane receptor consisting of one α subunit and a β, are only functional
to form the α-β heterodimer on the cell membrane. β1 family of integrins are major receptors
of ECM molecules and have the ability to allow cell adhesion and simultaneously issuing an
intracellular signal to which the cell responds in different ways, as also interact with integrins
the cytoskeleton and molecules involved in signal transduction.
It has been shown that integrins interaction with extracellular matrix molecules affects
cytoskeleton organization, proliferation, differentiation and gene expression in fibroblasts and
epithelial cells.
In addition we have studied the survival and differentiation of chondrocytes, including the
deposit in the interstitial matrix of collagen type X could be mediated by integrins [55].
Inhibition of integrin b1 subunit with a neutralizing antibody blocks the deposition of collagen
X in the interstitial matrix and growth of the breastbone is decreased. Moreover, the chondro‐
cytes are significantly smaller, show a disorganization of the actin cytoskeleton and show
increased apoptosis.
There is also evidence that blocking the β1 subunit of integrins in an in vitro model of
differentiation of cartilage inhibits cartilage nodule formation and the synthesis of collagen
type II [56].
However, the study of the role of these receptors in the process of chondrocyte differentiation
is not yet well established, but it would be of significant importance in determining the
relationship of the extracellular matrix to the chondrocyte.
5.1. The extracellular matrix and chondrocyte differentiation in osteoarthritis
Articular cartilage mineralization frequently accompanies and complicates osteoarthritis and
aging. Several works has demonstrated that certain features of growth cartilage development
are shared in degenerative cartilage. These include chondrocyte proliferation, hypertrophy,
matrix mineralization and apoptosis. Development of growth plate is regulated by growth
factors signaling and cellular interactions with the extracellular matrix (ECM). Parathyroid
Regenerative Medicine and Tissue Engineering372
hormone related protein (PthrP) and Indian Hedgehog (Ihh) are central mediators of endo‐
chondral development; PthrP is abundant in synovial fluid of osteoarthritic patient but Ihh
expression is diminish in OA cartilage, Fgf-18 is a regulator of chondrocyte proliferation and
its intra-synovial application in OA rat results in cartilage generation. Also, Wnt signaling
plays an important role in chondrocyte differentiation in growth plate, Wnt-5a promotes
chondrocyte prehypertrophy and inhibits chondrocyte hypertrophy unlike Wnt-4 that induces
chondrocyte hypertrophy and increases its expression in early stage of osteoarthritis. On the
other hand, is pronounced imbalance of cartilage matrix turnover in osteoarthritic cartilage,
and results in mayor deposition of collagen type I and X, reduced expression of collagen type
II. Thus, the rate of chondrocyte hypertrophy is higher on growth plate and OA articular
cartilage than healthy articular cartilage, it recap the signaling in cartilage growth plate. But,
although articular and growth plate cartilages share several features, there are one important
difference, the rate of cartilage hypertrophy. What is the signal that makes the difference? In
the ECM we could find some elements to answer this question.
5.1.1. Alterations in the extracellular matrix of articular cartilage during OA
Traditionally it has been thought that osteoarthritis is a disease of wear or tears consequence
of articular cartilage due to aging or following injury. The limited regenerative capacity of
cartilage cannot reverse its destruction, it is sometimes triggered by an inflammatory response
from the synovial, inflammation occurs when the condition is called osteoarthritis [57]. Until
recent years genetic mutations were excluded as a risk factor or predisposition to osteoarthritis.
The first genes identified to OA encode components of the extracellular matrix, such as
Collagen COL2A1, COL9A2 and COL11A2, which were studied in transgenic mouse models
[58]. It has been found that the substitution of glycine destabilizes the triple helix structure of
collagen type II making it more susceptible to degradation by MMP-13 [59]. Other ECM
molecules related to OA are ADAMTS-4 and ADAMTS-5 enzymes which degrade aggrecan,
the most abundant proteoglycan in articular cartilage [60]. When aggrecan is degraded, the
collagen II is exposed to the DDR-2 enzyme which is able to degrade it [61]. The alteration of
the ECM of articular cartilage in the first instance causes cell proliferation and the formation
of fibrous tissue that forms a scar in response to injury, there are produced growth factors such
as TGF-β could promote chondrocyte hypertrophy, so that recapitulates OA cartilage differ‐
entiation mechanisms of the growth plate to form ultimately bone nodules at the edges of
articular cartilage called osteophytes [62]. Clearly the importance of ECM in the differentiation
of articular cartilage, but there are various growth factors and transcription factors that
regulate the maturation and proliferation of chondrocytes in articular cartilage and cartilage
growth plate, which also control the expression of many of the components of the ECM, and
also direct the skeletal morphogenesis. Genes has recently been determined as Smad-3, Dkk,
Wnt4, Mig-6 etc [63- 66], OA generated in murine models, these molecules regulate different
cellular processes such as cell proliferation, cell differentiation, cell death, degradation and
synthesis of ECM. We can group the molecules according to the governing process: Chondro‐
genesis, Proliferation, Differentiation and Cell Death. Many of these molecules can be good
genetic markers of predisposition to OA, and are fundamental to how to design a strategy for
articular cartilage repair.
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5.1.2. Differentiation of articular cartilage chondrocyte
Although  exists  different  types  of  cartilage,  they  are  very  similar  but  have  different
functions. Articular cartilage and cartilage growth plate are good examples. In general, the
molecular  mechanisms  of  chondrocyte  differentiation  in  both  cartilages  are  equivalent.
However, for the function of synovial joints is essential that chondrocytes maintenance in
prehypertrophic state differentiation,  while the longitudinal  growth of  bone depends on
the proliferation and differentiation of chondrocytes in the growth plate to the hypertro‐
phy and bone formation [67, 68]. We can even talk about a model that relates the structure
and function of cartilage based on histological and functional differences of both cartilag‐
es. Both in the cartilage growth plate and in articular cartilage chondrocytes can be found
at various stages of differentiation, but the organization and activity of chondrocytes differ
in each stage of both cartilage.
In  the  growth  plate  chondrocytes  reserves  represent  an  immature  state  and  are  organ‐
ized in tiny rows of small round cells, embedded in an abundant extracellular matrix rich
in collagen type II and aggrecan, proliferating chondrocytes are stacked as "coins" several
rows forming compact occupying a large area of the growth plate, the first rows are more
proliferation activity than the rows deep; prehypertrofic chondrocytes (mature) are larger
cells that have exited the cell cycle and express Ihh, a key molecule in cartilage differentia‐
tion, these cells secrete and accumulate a large amount of carbohydrates and finally the
hypertrophic  chondrocytes  are  cells  of  highest  volume  and  high  alkaline  phosphatase
activity, the ECM is mainly composed of collagen type X and begins to calcify, some cells
degenerate and die by apoptosis leaving the spaces occupied to consolidate osteoblasts and
bone tissue. This process is known as endochondral ossification which regulates the growth
of bone in terms of cartilage differentiation. It is noteworthy that an important signaling
center  in  this  process  is  the  perichondrium,  which  are  very  small  and  flattened  cells
surrounding the cartilage and expressed PTHrP [69]  and Fgf-18 [70],  which respectively
induce and inhibit the proliferation of chondrocytes, the receiver PPR and PTHrP [71] is
expressed  in  the  upper  rows,  whereas  the  Fgf-18  receptor  and  FGF-R3  is  found in  the
deeper cell layers of proliferating chondrocytes. Patch is Ihh receptor and is expressed in
the perichondrium, so that Ihh induces the expression of PTHrP and this in turn induces
proliferation and expression of Ihh in the growth plate. This regulatory loop promotes the
longitudinal growth of the mold of cartilage, but it is necessary that the mold is rigid. For
this, the FGF18 inhibits the proliferation of cartilage to regulate expression of Ihh and this
result  in  the  differentiation of  chondrocyte  hypertrophy up.  This  signaling cascade also
occurs during the formation of joint cartilage, where bone formation is more limited as in
the secondary ossification centers.
Articular cartilage has apparently different stages of differentiation of chondrocytes, only that
which corresponds to the resting chondrocytes have important differences in the composition
of the ECM, as the presence of lubricin, the Collagen type IIa the aggrecan, CD44, ASC, [72,
73] these cells are most abundant in the articular cartilage cells for proliferation area are not
organized in rows and have very low proliferation rate, making them more similar to the
prehypertrophic cartilage, as the rate of is very slow maturation, hypertrophic chondrocytes
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make up a small area of just one or two cell lines the border between cartilage and bone, known
as "water mark" (tide mark).
5.2. Endochondral ossification during skeletal development and OA
The  joints  that  separate  from each  other  skeletal  elements  serve  as  important  signaling
centers  during  skeletal  development,  and  regulate  the  proliferation  and  maturation  of
chondrocytes.  It  is  well  known that  chondrocyte maturation is  crucial  for  endochondral
ossification and to define the final size of each skeletal element. In the end, the processes
of  the  formation  of  joints  and  cartilage  differentiation  of  skeletal  elements  are  strongly
related. The limb skeletal  elements are formed by endochondral ossification, the process
begins with the aggregation of mesenchymal cells that form the pre-cartilaginous conden‐
sation,  this  condensation  increases  the  proliferation  of  chondrocytes  and  forms  a  "bar"
initial cartilage [74]. It has been proposed that the first step for the formation of the joint
is that it inhibits differentiation of prehypertrofic chondrocytes in cells located in the region
of the joint prospecting,  outside the influence of  signals that  promote maturation of the
cartilage,  while  neighboring  cells  continue  their  differentiation  process  to  form  bone
hypertrophy  and  subsequently  by  endochondral  ossification,  so  contributing  to  the
formation of  adjacent skeletal  elements [75].  Cells  suspected joint  region form the inter‐
zone, characterized by a highly packed region of flattened cells, these cells produce other
types of collagen and collagen type I and III,  unlike chondrocytes that produce collagen
type  II.  The  interzone  also  expressed  molecules  such  as  Wnt-9a  [76]  and  Bmp  antago‐
nists  like noggin [77],  which remain the property of  these cells  not chondrogenic.  Some
cell  adhesion  molecules  such  as  integrin  α5β1  also  regulate  the  formation  of  joints  by
controlling the differentiation of chondrocytes [78], whereas other signaling molecules that
are expressed in the interzone as Wnt-4, Fgf-18, Gdf (5, 6 and 7) and several members of
the Bmp, promote growth and differentiation of adjacent cartilaginous elements [79]. It is
likely that different cell types present in a mature synovial joint, including synovial cells,
articular  chondrocytes  and  permanent  joint  capsule  cells  originate  in  the  interzone.
Permanent  articular  chondrocytes  originating  from  the  interzone,  are  very  similar  to
chondrocytes in the growth plate, and although both cell types are hyaline cartilage and
functions  have  important  differences.  The  most  important  difference  is  that  articular
chondrocytes  decrease  its  maturation  toward  hypertrophy  of  chondrocytes  unlike  the
growth  plate  which  we  observed  a  wide  region  of  hypertrophic  chondrocytes,  as  this
process allows for the ossification and growth of long bones. Hypertrophic chondrocytes
are the highest volume and produce a very specific extracellular matrix rich in collagen
type X. The hypertrophy of chondrocytes is followed by apoptosis, the invasion of blood
vessels, osteoclasts and other mesenchymal cells from the perichondrium and production
of bone matrix.  Therefore,  the size and fine structure of the long bones depends on the
coordinated  regulation  of  proliferation,  maturation  and hypertrophy of  chondrocytes  in
response  to  many extracellular  signals.  The  protein  Indian  hedgehog (Ihh)  and peptide
related to  Thyroid Hormone (PTHrP)  play a  critical  role  in  these  processes,  Ihh is  pro‐
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duced  by  prehypertrophic  chondrocytes  and  induces  the  expression  of  PTHrP  in  the
perichondrium which in turn regulates the rate of chondrocytes which exit the cell cycle
and continue to  hypertrophy [80].  Ihh also stimulates  proliferation of  chondrocytes  and
controls the differentiation of mesenchymal cells into osteoblasts in the collar bone. Thus,
when the chondrocytes stop expressing Ihh activates the expression of Runx-2 and Runx-3
[81], some transcription factors required for hypertrophy of chondrocytes and differentia‐
tion of osteoblasts. On the contrary, in particular FGF-18 [82] expressed in the perichondri‐
um  and  through  its  receptor  Fgf-R3  expressed  in  cartilage  prehypertrofic  cartilage
negatively regulates cell proliferation and promotes the hypertrophy of chondrocytes, the
constitutive activation of FGFR3 results in dwarfism [83] and may inhibit the formation of
joints,  this  confirms  the  idea  that  proliferating  chondrocytes  may  have  two  possible
destinations, become pre-articular chondrocytes or prehypertrophic chondrocytes.
5.3. Control of chondrocyte differentiation and two destinations, Ihh vs Wnt signaling and
its role in OA
During the formation of  the  skeleton some chondrocytes  are  involved in  the growth of
long bones and ossification.  At  this  early stage,  the GDF-5 signaling is  essential  for  the
formation  of  joints  and  articular  cartilage  [84,  85],  its  expression  is  delimited  in  the
interzone  and  begins  just  before  forming  the  joints,  on  the  other  hand,  the  Bmp-7  is
important  for  the  chondrocyte  maturation  and  bone  formation  and  is  expressed  in  the
perichondrium of the skeletal elements in formation and growth [86], but not expressed in
the  perichondrium  of  the  developing  cartilage.  Although  the  induction  of  the  joint  is
initiated by the expression of Wnt-9a in the interzone and the interzone chondrocytes lose
their  phenotype  [76],  GDF-5  signaling  is  essential  for  the  joint  and  articular  cartilage
formation. Ihh is another important molecule for skeletal development, Ihh inhibits Wnt-9a
expression and is maintained in skeletal growth and endochondral ossification, as when it
reaches  a  certain  size  decreases  the  expression of  Ihh and thereby activates  the  expres‐
sion of Wnt patway induces hypertrophy of chondrocytes and bone formation [87].  It  is
noteworthy that during the OA Wnt signaling is overactivated [65] and GDF-5 is down-
regulated,  which  suggests  a  recapitulation  of  endochondral  ossification  during  OA.
Furthermore, when the receptor Bmp-RIA is inactivated in mouse generated phenotypes
similar to human osteoarthritis and when activated the Wnt pathway by blocking antago‐
nist  Dkk  [64],  reverse  the  process  of  articular  cartilage  destruction  and  endochondral
ossification,  this  suggests  that  these pathways permit  the maintenance of  adult  articular
cartilage.
5.4. Proliferation, hypertrophy and cell death are activated during OA
Not only in the embryonic stages imbalance of proliferative signals and bring important
consequences hypertrophy in articular cartilage, osteoarthritis is a striking example of this
imbalance of signals. There are animal models that recapitulate this degenerative joint disease,
as in the case of the mutant mice of Smad-3 [63], a molecule that transduces the TGF-β signal.
Molecular analysis of these mice shows ectopic expression of type X collagen in the articular
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cartilage and increased hypertrophy of chondrocytes; this shows the TGF-β as an inhibitor of
differentiation of articular chondrocytes. Similarly, the cancellation of Mig-6 in mice results in
early degeneration of joints [66], as evidenced by degradation of articular cartilage, fibrous
tissue formation and growth of osteophytes. It is well known that articular cartilage injuries
may result in osteoarthritis, fibrous tissue formation is an immediate healing response to a
traumatic injury, and the healing is often promoted by TGF-β, which in turn could induce
osteophyte formation that recapitulates chondrogenesis and endochondral ossification in
adult articular cartilage.
5.5. Why not articular cartilage regenerate
During development are constantly chondrocytes proliferation and differentiation, thus
skeletal elements grow in length and ossify, as mentioned earlier, articular cartilage chondro‐
cytes have a low rate of proliferation and differentiation, this makes them different and allows
articular cartilage is kept almost throughout life. What keeps the ever-growing cartilage during
development is the molecular signals that modulate the rate of growth and differentiation,
these signals are regulated by the perichondrium. The perichondrium has progenitor cells that
are very useful for cartilage repair, its similar to bone, the periosteum is important for bone
repair, such as fractures. While the perichondrium is maintained until adult stages, the
perichondrium is disappearing from the stage young individuals, which is why the low
capacity of regeneration of cartilage [88].
6. Current methods for cartilage tissue engineering and future perspectives
6.1. Autologous chondrocytes for tissue regeneration
The hyaline articular cartilage is a highly specialized tissue and its main function is to protect
the bone from friction in the joints [89, 90], once articular cartilage is damaged their ability to
self-repair and regeneration is limited as mentioned above. Cartilage injuries are mainly
associated with anterior cruciate ligament, patellar dislocation, followed by a meniscectomy
[91]. Osteochondral lesions of the knee are determined mainly by arthroscopic knee surgery
[92, 93], which is seen mainly in traumatic injuries, together with abnormal stresses on the
knee.
To determine the treatment for the repair and regeneration of articular cartilage injury, have
developed different techniques, the techniques described are focused on the repair, recon‐
struction or regeneration of tissue. The repair methods (drilling or microfracture) support the
formation of new tissue fibrocartilaginous [94, 95] while the reconstructive method seeks to
fill the defect with allografts (OATS) combining with miniarthrotomy arthroscopy. And finally
the regenerative methods that rely on bioengineering techniques to develop a hyaline cartilage
tissue graft or autologous chondrocyte cell matrices (Table1).
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Ref. Method Technique Results
[96]
Drilling with
lavage and
debridement
Removal of osteophytes and knee abrasion
[97] Perform subchondral drilling of the lamina Tissue repair and pain relief
[98] Elimination of subchondral lamina
Significant symptomatic
improvementin 75% of patients
[99,
100]
Microfracture
Perforation of the subchondral lamina by arthroscopy, it
promotes the release of mesenchymal cells in the lesion, forming
a plug of tissue
Avoids necrosis associated with
the use of the drill and preserves
the subchondral surface.
The results observed in the
medium term, mainly in young
patients, about 20% of patients
do not reach after five years.
[101-
104]
Chondrogenesis
induced
stimulation of
bone marrow
(AMIC)
Followed by a micro abrasion bill and placing a collagen scaffold
on the defect, inducing the formation of fibrocartilage by
migrating mesenchymal cells and the expression of cytokines and
tissue repair
Stimulation of bone marrow has
limited mechanical strength and
may even degrade the cartilage is
repaired with fibrous tissue or
fibrocartilage so that there is
tissue degeneration.
[105-
107]
Mosaicplastyandt
ransplantosteoch
ondral allograft
Is based on obtaining osteochondral cylinder obtained from areas
of low load from the distal femur, which are grafted into the
defect
The results are limited in large
lesions due to donor site
morbidity and healing of the
seams in the recipient
[108-
110]
Autologous
chondrocyte
implantation
1st Generation: In this technique, cartilage cells are injected under
a cover of periosteum is sutured into the defect.
2nd. Generation: is replaced cover membrane or periosteum
biomaterials, which can have different components
It has been reported good results
in most patients after 10-20 years
after implantation.
In the second generation
transplants with areas of
fibrocartilage, possibly because of
low cell density and lack of
proliferative capacity. This
technique replaces healthy
cartilage to regularize the defect.
[111]
Autologous
chondrocyte
implantation
induces
extracellular
matrix
3rd. Generation: In this technique, autologous chondrocytes
cultured on a three-dimensional artificial scaffold
Has been used in the past two
decades, with this type of
membranes hypertrophy is
reduced by 5%, after 3 to 6
months membrane is reabsorbed.
Table 1. Cartilage repair techniques
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Each of these procedures is associated with improvement of these techniques with the use of
biomaterials or with the use of growth factors. In the autologous chondrocyte implantation of
the second generation is required arthrotomy so this technique becomes more complicated. In
order to facilitate and improve the technique and quality of the tissue repair, has developed a
method which has proved more effective and easy to implement in the knee joint [112, 113]
develop and autologous chondrocyte implantation induced extracellular matrix of the third
generation.
6.2. Description of the technique of autologous chondrocyte implantation induced
extracellular matrix (third generation).
6.2.1. Obtaining the tissue
This technique is mainly based on the autologous cultured chondrocytes on a biocompatible
three-dimensional scaffold which is subsequently implanted into the defect. As in the techni‐
que of autologous chondrocyte implantation of the second generation, it requires a prior
arthroscopic surgery where a piece of cartilage obtained from a zone of no load of the knee
joint (intercondylar notch or the lateral edge of the trochlea) after obtaining the sample
fragment is processed to obtain chondrocytes in culture.
6.2.2. Implant preparation
Cartilage fragments are disintegrated mechanically to obtain smallest fragment, is performed
subsequent enzymatic digestion to release trapped chondrocytes in the matrix of collagen.
Expansion of chondrocytes was performed in 8 weeks. Days before implantation chondrocytes
are seeded on a scaffold or membrane [112] Rich in collagen, which is considered a three-
dimensional extracellular biomaterial consists mainly of collagen I and III, the scaffold contains
glycosaminoglycans, proteoglycans and glycoproteins [111, 114, 115] cells are capable of
synthesizing a typical matrix of chondrocytes facilitating cell adhesion and influence the
morphology, migration and differentiation of cells.
6.3. Advantages of autologous chondrocyte transplantation induced extracellular matrix
(third generation) on the autologous chondrocyte implantation (second generation)
The main advantages of autologous chondrocyte transplantation induced extracellular matrix
(third generation) is that no cell loss is not presented hypertrophic tissue growth, requiring
only a second incision is a safe procedure for treatment of injuries symptomatic articular
cartilage surgery facilitates reducing the operating time and the need for open surgery
compared to traditional surgery for autologous chondrocyte implantation (second generation).
While in the second generation technique leads to form hyaline cartilage on the surface
showing fibrosis and proliferation of small blood vessels (reactive fibrosis), by the use of
periosteum, so that in this case it is advisable the use of membrane collagen
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7. New proposals for repairing articular cartilage
In recent years they have sought new strategies for cartilage repair, with technological
advances have currently been proposed the use of scaffolding or matrix on which cells can
grow. Among the scaffolds used in the clinic (Table 2) are those that are based on collagen,
hyaluronic acid and fibrin as these provide a substrate normally found in the structure of native
articular cartilage. Collagen is a major extracellular matrix protein, exists to provide strength
and stability to the connective tissues. At the clinic is used collagen I-III as scaffolds for growing
chondrocytes in order to improve the structural and biological properties of the graft [116,
117] this is used as a sponge, foam, gel and membrane form, all these are subject to enzymatic
degradation. Hyaluronic acid is another important component of articular cartilage matrix and
is a glycosaminoglycan that is involved in homeostasis [118, 119] provides viscoelasticity to
synovial fluid, is credited as a lubricant and shock absorbing properties, is essential for the
correct structure of proteoglycans in articular cartilage. Between scaffolds containing hyalur‐
onic acid is the Hylaff-11, which is an esterified derivative of hyaluronic acid and is used for
growing chondrocytes in three dimensions, has been shown that when using this type of
scaffold maintaining the chondrocyte phenotype, so that chondrocytes are capable of produc‐
ing the proteins and molecules characteristic of a hyaline cartilage [120-122]. Fibrin is a protein
involved in blood coagulation, is regarded as a biomaterial for cartilage repair, as can be found
in gel form, having an adhesive function that is also biocompatible and biodegradable [123].
However in vivo studies in animals have shown to have low mechanical stability and can also
trigger an immune response [124, 125], fibrin because this has only been used clinically to
ensure healthy cartilage tissue-engineered the [126-128].
Based on the foregoing and which is being used in the clinic and according to results obtained
in patients who have been treated with different biomaterials has been observed that although
there is a suitable biomaterial that contributes to the production of extracellular matrix to
provide the right conditions for chondrocyte cell differentiation. So it is necessary to propose
new biomaterials that help produce extracellular matrix, capable of activating a cascade of
signaling that can form a cartilage which has structural properties suitable for tissue repair, as
well as having viscoelastic properties and to provide mechanical stability.
8. Cartilage tissue engineering and low scaffold successful
Many advances in the field of cartilage tissue engineering have been closely connected to the
improved performance of biomaterials. Successful cartilage tissue engineering relies on four
specific criteria: (1) cells, (2) signaling molecules, (3) biomaterials, and the (4) mechanical
environment. Furthermore, they should be biocompatible, non-toxic, bioresorbable and highly
permeable to facilitate mass transport [139].
The use of scaffolds to support replication of chondrocytes for production of cartilage in vitro
has been the most common approach for tissue engineering of cartilage, however, despite the
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apparent simplicity of cartilage, to our knowledge, tissue engineered cartilage has not been
successfully reached so far [140-142].
In theory, a scaffold for tissue engineering should have a three dimensional porous structure
forming an interconnected porous network. These structures should be made of biocompatible
and biodegradable materials capable to provide mechanical strength, support cells ingrowth,
promote cells adhesion, uniform cell spreading, and conserve phenotypes and functional
characteristics of transplanted cells [143,144]. Unfortunately, this list of requirements looks too
long and hard to accomplish. Probably this is one of the main reasons of why the advances in
cartilage engineering have been too slow. But also we should rethink these concepts in order
to find shorter and easier pathways to find more efficient and effective tissue engineering
methods.
Ref. Biomaterial Component Method of autologousChondrocyte transplantation Results
[126,
129-
132]
Carticel
Collagen I-III
2nd and 3rd generation Three-dimensional multi-layer
keeps the chondral phenotype
[113] Matricel 2nd generation
[133,
134] CaReS®
Collagen I
hydrogel 2nd generation
It presents a significant functional
improvement as well as acting on
the levels of pain.
[135-
136] Hyalograft-C
Hyaluronic
acid
3rd generation
Maintaining the chondral
phenotype, absence of
inflammatory response, formation
of hyaline cartilage
[137] Hyalgan® --------------
Indicated for the treatment of
osteoarthritis of the knee,
improves mobility and reduces
pain.
[113] Tisseel Fibrin 3rd generation
Fibrin is an integral component of
the extracellular matrix induced
chondrocytes, so that the new
cartilage is well integrated into
the underlying subchondral bone.
Moderate application of fibrin
[138] Cartipatch
Alginate
Hydrogel-
agarose
--------
Hyaline cartilage was observed in
eight of the 13 patients treated,
clinical improvement at 2 years of
treatment
Table 2. Biomaterials most used in the clinic, with different components for the repair of articular cartilage by
autologous transplantation method of chondrocytes from second and third generation.
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The vast majority of scaffolds used in tissue engineering are solid sponge-like porous struc‐
tures that are seeded with cells in a culture media. Analyzing this approach from the basic
principles for the design of biomaterials, the biomimetism, easily we can find out that this
process lacks of this basic concept. In natural tissues, cells grow in a physiological environment
which is more like a gel medium than a porous scaffold, they do not form tissues by populating
porous structures, but they do it by creating their own ECM starting from a gel-like environ‐
ment. Following this line, many researchers are proposing the encapsulation of cells in
hydrogels instead of using porous scaffolds, looking to improve the biomimetic environment
for cells [145,146,147,148].
Besides biomimetism, sponge-like scaffolds provides only a two dimensional surface for cell
attachment, although their structure is 3D, cells attach to the walls of the scafflod, thus
changing completely the way they are integrated into natural tissues. On the other hand
hydrogels are capable to provide a real 3D environment when cells are seeded (encapsulated)
into them [149].
8.1. Hydrogels for articular cartilage tissue engineering
Hydrogels are water-swollen, cross-linked polymeric structures [150] that possess unique
mechanical and chemical properties that make them very attractive for a variety of biomedical
applications; actually there are no other materials capable to display characteristics too close
to natural tissues such as Hydrogels. Therefore hydrogels have been considered as a key
material in the development of new biomaterials for tissue engineering and artificial organs
fabrication.
Their particular properties come from their structure, composed of swollen randomly cross‐
linked networks of rod-like polymer chains with water filling the interstitial spaces.[151] Water
commonly comprises more than 80% of the total volume. The physical properties of hydrogels
are determined by the polymer composition and concentration, the cross-linking density
between polymer chains [152], polymerization conditions [153], the addition of hydrophobic
monomers which may create regions of more dense coiled or entangled chains, the introduc‐
tion of composite materials such as rubber or glass, the use of cross-linking agents such as
glutaraldehyde, and the use of freeze-thawing procedures to induce partial crystallinity [154].
Hydrogels can be classified by the type of crosslinking: covalently or ionic cross-linked,
physical gels, or entangled networks [155]. The two first are the most common gels. Physical
gels are formed by non-covalent interactions, such as hydrogen bonding, and hydrophobic
interactions [156]. Covalently or ionic cross linked gels are considerably more stable than
physical gels and once they are formed they may not be re-melted again.
Hydrogels can be obtained from natural or synthetic polymers. Natural hydrogels come from
proteins and polypeptides (commonly collagen and gelatin), polysaccharides (i.e. alginate,
agarose, hyaluronic acid, fibrin, chitin and chitosan). On the other hand, synthetic polymers
come from man-made materials such as polyester (i.e. poly L-lactic and polyglycolic acid, poly
ε-caprolactone, polypropylene fumarate), polyethylene oxide, polyethylene glycol, polyvinyl
Regenerative Medicine and Tissue Engineering382
alcohol, polyurethane, polydiol citrates, polyhydroxyethyl methacrylate, and many others
polymers [157].
Although hydrogel scaffolding technologies plays a crucial role in cartilage tissue engineering,
several studies has been shown low success cartilage tissue repair. They are unable to generate
cartilaginous tissues with similar properties to native cartilage [141-142].
There are a number of reasons for scaffolds failure, we summarized some of them:
1. The scaffold architecture should be designed to mimic the depth-dependent heterogeneity
of articular cartilage structure or to generate multiphasic scaffolds to promote the
simultaneous growth of bone and cartilage with a stable interface for engineering
osteochondral tissue.
2. However, manufacturing scaffolds technologies are limited and no optimum architec‐
tures have been produce yet.
3. The study of biological cartilage development is still growing.
4. Not enough knowledge about:
5. the role of chondrocyte ECM and their implications during chondrogenesis.
6. the role of adhesion molecules and signaling pathways during chondrogenesis.
7. Culture chondrocytes in vitro and density cells conditions in scaffolds.
8. Dynamic cartilage ECM and their Nanomechanical properties.
9. Chemical variables in cell-scaffolds interactions, among others.
8.2. Trends in hydrogel-scaffolding cartilage repair
However towards designing biomimetic native environments cartilage is still a challenge due
articular cartilage is intricately organized and heterogeneous tissue. This tissue reveals a highly
defined structural organization that can be subdivided into two domains, the cartilage zones
and the organization of the extracellular matrix. In that sense the ECM of articular cartilage is
a unique environment with complex heterogeneity and spatial conformation very difficult to
mimic. One of the most notable variations in this tissue is the spatial organization of collagen
network and cells arrangement. [141]. Moreover cartilage presents different morphology, gene
expression, matrix spatial array between cultured populations isolated from distinct cartilage
zones [142]. However, intensive researches have been focus on the development of an ideal
scaffold material with versatile properties that actively contribute to cartilage repair [158]. In
that regard, there have been several attempts trying to recreate the different zones in cartilage
by different hydrogel fabrication technologies, giving as a result tridimensional homogeneous
structures with little resemblance to the native organization in cartilage, so it is necessary to
material scientists thinking in others design hydrogel-scaffolding strategies trying to biomi‐
metic hierarchical structures capable to deliver bioactive molecules such as growth factors with
an ideal mechanical response and mediated by adhesive molecules in order to have an
integration tissue [159].
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Currently strategies in the design of biomimetic cartilage hydrogels are governed by the use
of collagen Type I and derived from porcine small intestine submucosa implants. Although
the chondrocytes typically lose their phenotype, the gene expression patterns changed when
they are removed from their native environment, so give them a proper environment is
necessary to keep its phenotype of chondrocytes in different populations to recreate the zonal
organization [160]. In addition, biological trials in vitro be made taking into account the cell
density for each zone [161,162].
According with reference [163] concentrations of 12-25 million cells/cm2 are needed to increase
the matrix production and mechanical properties of human adult chondrocytes under static
conditions. Nevertheless, material researches are focus on fabrication of three-dimensional
artificial arrays in form of hydrogels using macromolecules present in the cartilage inter-
territorial matrix and trying to mimic the distinct cartilage zonal [160]; however, no substantial
data of the formation of cartilage are reported.
Others approaches in cartilage tissue engineering are the use of hydrogel culture employed
mesenchymal stem cells (MSCs) and the use of bioreactors in order to provide the necessary
biochemical and biomechanical stimulations to enhance chondrogenesis [164,165]. Due to the
many mentioned limitations related to chondrocyte sources, there is much effort to explore
better alternative cell sources. Desirable characteristics for such sources include accessibility,
availability, and chondrogenic capacity. Consequently, stem cells such as adult mesenchymal
stem cells (MSCs) have emerged as promising cell sources for articular cartilage tissue
engineering. Chondrogenic potentials of MSCs from different tissues have also been investi‐
gated and compared. Specifically, MSCs from bone marrow are the most popular considering
they are easily harvested (via the iliac crest) and have good chondrogenic potential. Many in
vitro and in vivo studies have revealed promising results of marrowderived MSCs combined
with various biomaterials or growth factors for repairing cartilage defects [164,166]. Recently,
Johnson et al. describe the discovery and characterization of kartogenin, a small molecule that
induced stem cells to take on the characteristics of chondrocytes and improves joint function
and promotes the regeneration of cartilage in vivo in two rodent models of chronic and acute
joint [166].
Mechanical stresses are an important factor of chondrocyte function as they stimulate them to
increase the synthesis of ECM components. In cartilage culturing processes the main types of
mechanical forces currently being investigated are hydrostatic pressure, direct compression,
shear environments [167, 168].
Finally, to better recapitulate the ECM environment for cartilage tissue engineering, research‐
ers have to introduce several biological signals, including chondroitin sulfate (CS), hyaluronic
acid (HA), and collagen type I and II, into tissue-engineered scaffolds to encourage tissue
specificity [169]. CS, hyaluronic acid, and collagen type II have been shown to promote or
enhance chondrogenesis of mesenchymal stem cells (MSCs) in hydrogel-based culture
systems. In addition to the physical cues of native matrix, cells are exposed to an array of
biological cues throughout the ECM that direct cellular behavior.
Regenerative Medicine and Tissue Engineering384
Cells are constantly interacting with the surrounding ECM, which gives rise to a dynamic
transfer of information between the extracellular and intracellular space. In addition, biological
trials in vitro be made taking into account the cell density for each zone [169].
Tissue engineering should be the best way to achieve successful cartilage regeneration by
combining novel biologically inspired scaffolds approaches, nanotechnology, cell sources such
as stem cells, chondrogenic factors, and physical stimuli [165].
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